Ramblings from a cytotech mind

3 views
Skip to first unread message

cellist

unread,
Apr 15, 2006, 4:23:42 PM4/15/06
to CYTOPATHNET-L
I took MIME, and was not impressed with it being too easy, too hard,
unfair, poorly stained, tricky, etc. We all passed.

Npw the NYSDH wants us to test again with them, after passing MIME.

Progress sometimes feels like running through the mud (?)

Happy Easter, wherever applicable, people!

Cellist

Sandra Fite

unread,
Apr 16, 2006, 6:14:26 AM4/16/06
to CYTOPA...@googlegroups.com
What I think is strange is that we have not had any comments good, bad or
indifferent about the CAP PT.

Sandra K. Fite, CT(ASCP)

Sullinger, Jana - MD

unread,
Apr 17, 2006, 9:08:30 AM4/17/06
to CYTOPA...@googlegroups.com
<snipped> Subject: [CYTOPATHNET-L] Re: Ramblings from a cytotech mind

<<What I think is strange is that we have not had any comments good, bad
or indifferent about the CAP PT.
<<Sandra K. Fite, CT(ASCP)

I suspect the reason we haven't heard much about the CAP PT test is that
not many have taken it yet. I suspect most waited until April or June
timeframe of 2005 to even take. I think we will start to hear something
soon.

I switched our lab over, with a request for a September 2006 test date,
and received back from CAP a Feb 2006 test date! I called to ask why
this date, and they had made a mistake with our signup. The system
incorrectly put us with a Feb 2006 test date even though our application
clearly stated September. The problem was quickly resolved, but it
appears the CAP process isn't bugproof either :)

JCS
--------------------------
Jana C. Sullinger, MD
Director of Women's Health Services
Director of Quality Improvement
Chair, AmeriPath Women's Health Diagnostics Resource Committee
AmeriPath Alpha Rd
mailto:jsull...@ameripath.com
Ph: 972-934-4384
FAX: 972-404-2530
----------------------
CONFIDENTIALITY NOTICE: This e-mail message, including any attachments,
is for the sole use of the intended recipient(s) and may contain
confidential and privileged information. Any unauthorized review, use,
disclosure or distribution is prohibited. If you are not the intended
recipient, please contact the sender by reply e-mail and destroy all
copies of the original message.

Sullinger, Jana - MD.vcf
Reply all
Reply to author
Forward
0 new messages